Search Results - "Silvestris, N."

The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies by Russo, A., Incorvaia, L., Del Re, M., Malapelle, U., Capoluongo, E., Gristina, V., Castiglia, M., Danesi, R., Fassan, M., Giuffrè, G., Gori, S., Marchetti, A., Normanno, N., Pinto, C., Rossi, G., Santini, D., Sartore-Bianchi, A., Silvestris, N., Tagliaferri, P., Troncone, G., Cinieri, S., Beretta, G.D.

“…The term liquid biopsy (LB) refers to the use of various biological fluids as a surrogate for neoplastic tissue to achieve information for diagnostic,…”
Get full text

Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center by Ruggeri, R. M., Spagnolo, C. C., Alibrandi, A., Silvestris, N., Cannavò, S., Santarpia, M.

“…Background Thyroid dysfunction is among the most common immune-related adverse events (irAEs) of immune checkpoint inhibitors (ICIs) therapy. Data regarding…”
Get full text

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer by Fornaro, L, Cereda, S, Aprile, G, Di Girolamo, S, Santini, D, Silvestris, N, Lonardi, S, Leone, F, Milella, M, Vivaldi, C, Belli, C, Bergamo, F, Lutrino, S E, Filippi, R, Russano, M, Vaccaro, V, Brunetti, A E, Rotella, V, Falcone, A, Barbera, M A, Corbelli, J, Fasola, G, Aglietta, M, Zagonel, V, Reni, M, Vasile, E, Brandi, G

“…Background: The role of second-line chemotherapy (CT) is not established in advanced biliary tract cancer (aBTC). We investigated the outcome of aBTC patients…”
Get full text

Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study by Santini, D., Tampellini, M., Vincenzi, B., Ibrahim, T., Ortega, C., Virzi, V., Silvestris, N., Berardi, R., Masini, C., Calipari, N., Ottaviani, D., Catalano, V., Badalamenti, G., Giannicola, R., Fabbri, F., Venditti, O., Fratto, M.E., Mazzara, C., Latiano, T.P., Bertolini, F., Petrelli, F., Ottone, A., Caroti, C., Salvatore, L., Falcone, A., Giordani, P., Addeo, R., Aglietta, M., Cascinu, S., Barni, S., Maiello, E., Tonini, G.

“…Data are limited regarding bone metastases from colorectal cancer (CRC). The objective of this study was to survey the natural history of bone metastasis in…”
Get full text

Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target by De Vita, F, Giuliani, F, Silvestris, N, Catalano, G, Ciardiello, F, Orditura, M

“…SUMMARY Surgery is the only curative therapy for gastric cancer. In the metastatic setting the objective of treatment is to manage symptoms, improve quality of…”
Get full text

Integrative characterization of pancreatic ductal adenocarcinoma with poorly cohesive / signet ring cells by Luchini, Claudio, Simbolo, M., Silvestris, N., Mafficini, A., Maggino, L., Malleo, G., Mattiolo, P., Salvia, R., Lawlor, R., Scarpa, A.

Get full text

Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey by Reni, M., Giommoni, E., Bergamo, F., Cavanna, L., Simionato, F., Spada, M., Di Marco, M., Bernardini, I., Cordio, S.S., Latiano, T., Spallanzani, A., Silvestris, N., Cardellino, G.G., Bonomi, M., Milella, M., Luchena, G., Tamburini, E., Macchini, M., Orsi, G., Modesti, M., Procaccio, L., Santoni, A., De Simone, I., Caldirola, L., Galli, F., Pinto, C.

“…This analysis from the GARIBALDI study was aimed to address the role of center self-declared expertise, type and commitment on the overall survival (OS) of…”
Get full text

Synthesis and biological evaluation of N-biphenyl-nicotinic based moiety compounds: A new class of antimitotic agents for the treatment of Hodgkin Lymphoma by Porcelli, L., Stolfa, D., Stefanachi, A., Di Fonte, R., Garofoli, M., Iacobazzi, R.M., Silvestris, N., Guarini, A., Cellamare, S., Azzariti, A.

“…We previously demonstrated that some N-biphenylanilides caused cell-cycle arrest at G2/M transition in breast cancer cells. Among them we choose three…”
Get full text

Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM) by Pedrazzoli, P., Baldanti, F., Donatelli, I., Castrucci, M.R., Puglisi, F., Silvestris, N., Cinieri, S.

“…Influenza virus causes annual epidemics in the winter–spring season with significant morbidity in the general population and important mortality in high-risk…”
Get full text

Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view by Natalicchio, A., Marrano, N., Montagnani, M., Gallo, M., Faggiano, A., Zatelli, MC, Argentiero, A., Del Re, M., D’Oronzo, S., Fogli, S., Franchina, T., Giuffrida, D., Gori, S., Ragni, A., Marino, G., Mazzilli, R., Monami, M., Morviducci, L., Renzelli, V., Russo, A., Sciacca, L., Tuveri, E., Cortellini, A., Di Maio, M., Candido, R., Perrone, F., Aimaretti, G., Avogaro, A., Silvestris, N., Giorgino, F.

“…Background: Increasing evidence suggests that diabetes increases the risk of developing different types of cancer. Hyperinsulinemia, hyperglycemia and chronic…”
Get full text

Ang-2 polymorphisms in relation to outcome in advanced HCC patients receiving sorafenib by Casadei Gardini, A., Marisi, G., Scartozzi, M., Faloppi, L., Silvestris, N., Brunetti, O.

Get full text

Adjuvant colon cancer chemotherapy: where we are and where we'll go by Lombardi, L, Morelli, F, Cinieri, S, Santini, D, Silvestris, N, Fazio, N, Orlando, L, Tonini, G, Colucci, G, Maiello, E

“…SUMMARY Many patients with early-stage colon cancer are cured with surgery alone, even if the standard of care remains an uniform approach to adjuvant…”
Get full text

Sorafenib in patients with hepatocellular carcinoma: 10 years of real life by Rovesti, G., Orsi, G., Faloppi, L., Gramantieri, L., Silvestris, N., Marisi, G., Foschi, F., Tamburini, E., Andrikou, K., Molinaro, E., Riggi, M., Scartozzi, M., Cascinu, S., Gardini, A. Casadei

Get full text

Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM) by Pedrazzoli, P., Lasagna, A., Cassaniti, I., Ferrari, A., Bergami, F., Silvestris, N., Sapuppo, E., Di Maio, M., Cinieri, S., Baldanti, F.

“…Herpes zoster (HZ) is the infectious reactivation of the varicella-zoster virus. HZ is more frequent in immunocompromised subjects, including patients with…”
Get full text

Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) by Pedrazzoli, P., Lasagna, A., Cassaniti, I., Piralla, A., Squeri, A., Bruno, R., Sacchi, P., Baldanti, F., Di Maio, M., Beretta, G.D., Cinieri, S., Silvestris, N.

“…Patients with cancer have a well-known and higher risk of vaccine-preventable diseases (VPDs). VPDs may cause severe complications in this setting due to…”
Get full text

Multicentric prospective study of validation of angiogenesis-related gene polymorphisms in hepatocellular carcinoma patients treated with sorafenib: results of INNOVATE study by Casadei Gardini, A., Marisi, G., Dadduzio, V., Ielasi, L., Vivaldi, C., Rizzato, M., Fornaro, L., Lonardi, S., Gramantieri, L., Pecora, I., Foschi, F., Silvestris, N., Fornari, F., Orsi, G., Rovesti, G., Santini, D., Zagonel, V., Cascinu, S., Scartozzi, M.

Get full text

Metformin effects on clinical outcome in advanced HCC patients receiving sorafenib: validation study by Faloppi, L., Floppi, L., Silvestris, N., Brunetti, O., Santini, D., Scartozzi, M., Casadei Gardini, A.

Get full text

MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view by Natalicchio, A., Montagnani, M., Gallo, M., Marrano, N., Faggiano, A., Zatelli, M.C., Mazzilli, R., Argentiero, A., Danesi, R., D’Oronzo, S., Fogli, S., Giuffrida, D., Gori, S., Ragni, A., Renzelli, V., Russo, A., Franchina, T., Tuveri, E., Sciacca, L., Monami, M., Cirino, G., Di Cianni, G., Colao, A., Avogaro, A., Cinieri, S., Silvestris, N., Giorgino, F.

“…Increasing evidence suggests that patients with diabetes, particularly type 2 diabetes (T2D), are characterized by an increased risk of developing different…”
Get full text

Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper by Gallo, M., Adinolfi, V., Morviducci, L., Acquati, S., Tuveri, E., Ferrari, P., Zatelli, M.C., Faggiano, A., Argentiero, A., Natalicchio, A., D'Oronzo, S., Danesi, R., Gori, S., Russo, A., Montagnani, M., Beretta, G.D., Di Bartolo, P., Silvestris, N., Giorgino, F.

“…Pancreatic cancer (PC) is a common cause of cancer-related death, due to difficulties in detecting early-stage disease, to its aggressive behaviour, and to…”
Get full text

Role of liposomal anthracyclines in breast cancer by Lorusso, V, Manzione, L, Silvestris, N

“…Anthracyclines are among the most effective drugs for patients with breast cancer. Their use, however, has been limited by associated toxic effects, including…”
Get full text